Categories
Jump to navigation
Jump to search
The following categories exist on the wiki, and may or may not be unused. Also see wanted categories.
(first | last) View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)- 5 alpha-reductase inhibitors (2 members)
- ACVR1 inhibitors (1 member)
- AKT1 inhibitors (4 members)
- ALK inhibitors (9 members)
- AXL inhibitors (2 members)
- AbbVie product (1 member)
- Acid pump antagonists (1 member)
- Acquired coagulopathy medications (2 members)
- Acquired coagulopathy regimens (1 member)
- Acquired hemophilia A medications (7 members)
- Acquired hemophilia A regimens (1 member)
- Acquired thrombotic thrombocytopenic purpura medications (7 members)
- Acquired thrombotic thrombocytopenic purpura regimens (1 member)
- Acute leukemias (15 members)
- Acute lymphoblastic leukemia, infant medications (4 members)
- Acute lymphoblastic leukemia, infant regimens (2 members)
- Acute lymphoblastic leukemia medications (1 member)
- Acute lymphoblastic leukemia regimens (3 members)
- Acute lymphoblastic leukemias (10 members)
- Acute myeloid leukemia medications (40 members)
- Acute myeloid leukemia medications (historic) (11 members)
- Acute myeloid leukemia medications (investigational) (10 members)
- Acute myeloid leukemia regimens (9 members)
- Acute promyelocytic leukemia medications (16 members)
- Acute promyelocytic leukemia regimens (2 members)
- Adrenal suppressant (1 member)
- Adrenergic receptor agonists (1 member)
- Adrenocortical carcinoma medications (6 members)
- Adrenocortical carcinoma medications (investigational) (1 member)
- Adrenocortical carcinoma regimens (2 members)
- Adult T-cell leukemia-lymphoma medications (17 members)
- Adult T-cell leukemia-lymphoma regimens (2 members)
- Adult T-cell leukemia/lymphoma medications (0 members)
- Adult T-cell leukemia/lymphoma regimens (0 members)
- Aggressive lymphomas (7 members)
- Aggressive non-Hodgkin lymphomas (11 members)
- Alkalinization (1 member)
- Alkyl sulfonates (1 member)
- Alkylating agents (34 members)
- Allogeneic HSCT regimens (1 member)
- Alloimmune hematologic conditions (1 member)
- Alpha emitters (1 member)
- Alveolar soft part sarcoma medications (1 member)
- Alveolar soft part sarcoma regimens (1 member)
- Aminopeptidase inhibitor (1 member)
- Anabolic steroids (2 members)
- Anal cancer medications (11 members)
- Anal cancer regimens (1 member)
- Anaplastic glioma medications (16 members)
- Anaplastic glioma regimens (2 members)
- Anaplastic large cell lymphoma, pediatric medications (1 member)
- Anaplastic large cell lymphoma medications (14 members)
- Anaplastic large cell lymphoma regimens (2 members)
- Androgen receptor inhibitors (1 member)
- Angiosarcoma medications (3 members)
- Angiosarcoma regimens (1 member)
- Anthracenedione (1 member)
- Anthracyclines (12 members)
- Anti-BCMA-CD3 bispecific antibodies (2 members)
- Anti-BCMA/CD3 bispecific antibodies (0 members)
- Anti-BCMA CAR T-cells (2 members)
- Anti-BCMA antibodies (1 member)
- Anti-BCMA antibody-drug conjugates (1 member)
- Anti-BCMA bispecific T-cell engager antibodies (0 members)
- Anti-BCMA cellular therapy (2 members)
- Anti-C1s antibodies (1 member)
- Anti-C5 antibodies (4 members)
- Anti-CCR4 antibodies (1 member)
- Anti-CD137 cellular therapy (4 members)
- Anti-CD19-CD3 bispecific antibodies (1 member)
- Anti-CD194 antibodies (1 member)
- Anti-CD19 BiTE antibodies (0 members)
- Anti-CD19 CAR T-cells (4 members)
- Anti-CD19 antibodies (2 members)
- Anti-CD19 antibody-drug conjugates (3 members)
- Anti-CD19 bispecific T-cell engager antibodies (0 members)
- Anti-CD19 cellular therapy (4 members)
- Anti-CD20-CD3 bispecific antibodies (3 members)
- Anti-CD20 BiTE antibodies (0 members)
- Anti-CD20 antibodies (14 members)
- Anti-CD20 bispecific T-cell engager antibodies (0 members)
- Anti-CD20 cellular therapy (0 members)
- Anti-CD20 radioimmunoconjugates (2 members)
- Anti-CD22 antibodies (3 members)
- Anti-CD22 antibody-drug conjugates (1 member)
- Anti-CD22 immunotoxins (2 members)
- Anti-CD27 antibodies (1 member)
- Anti-CD28 cellular therapy (2 members)
- Anti-CD30 antibodies (1 member)
- Anti-CD30 antibody-drug conjugates (1 member)
- Anti-CD33-CD3 bispecific antibodies (1 member)
- Anti-CD33/CD3 bispecific antibodies (0 members)
- Anti-CD33 antibodies (2 members)
- Anti-CD33 antibody-drug conjugates (2 members)
- Anti-CD33 bispecific T-cell engager antibodies (0 members)
- Anti-CD33 radioimmunoconjugates (1 member)
- Anti-CD37 antibodies (1 member)
- Anti-CD37 medications (0 members)
- Anti-CD38 antibodies (5 members)
- Anti-CD3 antibodies (0 members)